Peters, K.E.; Joubert, I.A.; Bringans, S.D.; Davis, W.A.; Lipscombe, R.J.; Davis, T.M.E.
PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes. Diagnostics 2025, 15, 662.
https://doi.org/10.3390/diagnostics15060662
AMA Style
Peters KE, Joubert IA, Bringans SD, Davis WA, Lipscombe RJ, Davis TME.
PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes. Diagnostics. 2025; 15(6):662.
https://doi.org/10.3390/diagnostics15060662
Chicago/Turabian Style
Peters, Kirsten E., Isabella A. Joubert, Scott D. Bringans, Wendy A. Davis, Richard J. Lipscombe, and Timothy M. E. Davis.
2025. "PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes" Diagnostics 15, no. 6: 662.
https://doi.org/10.3390/diagnostics15060662
APA Style
Peters, K. E., Joubert, I. A., Bringans, S. D., Davis, W. A., Lipscombe, R. J., & Davis, T. M. E.
(2025). PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes. Diagnostics, 15(6), 662.
https://doi.org/10.3390/diagnostics15060662